简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-03-10 10:41 Tanner Pharma Group Expands Ex-US Access Program to Provide LEUKINE® for Use in Patients with Respiratory Illness Associated with COVID-19
2021-03-09 16:01 Covetrus Announces Vice President of Global Talent Management
2021-03-09 14:06 IntelliCentrics Launches Patient-Centric Visitor Management Transforming Healthcare Across China, North America, and the UK
2021-03-09 10:00 Health Insurance Premiums Have Decreased in a Number of Countries, According to Pacific Prime’s Latest Report
2021-03-08 14:32 Vifor Pharma and Cara Therapeutics announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus
2021-03-08 10:03 Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
2021-03-05 18:22 TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round
2021-03-04 16:38 COVID-19 Vaccine Adjuvant Potentials of Nichi Glucan Dietary Supplement From Japan
2021-03-04 16:21 Galderma Continues Global Growth Ambition With Sculptra® (injectable poly-L-lactic Acid) Re-launch in Europe
2021-03-04 14:06 Toshiba Launches Thin and Compact LDO Regulators That Help to Reduce Device Size and Stabilize Power Line Output
2021-03-04 09:54 Masimo Announces CE Marking of the Rad-G™ with Temperature
2021-03-03 18:37 Theramex Launches New Website
2021-03-03 17:13 RefleXion Adds Ally Bridge Group to Investor Syndicate
2021-03-03 14:20 Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1
2021-03-03 12:08 Market Survey by TSUNO Group Reveals “Rice Bran Oil” Market in Japan Is Expanding Under COVID-19 Pandemic
2021-03-03 11:18 ReViral and LianBio Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Sisunatovir in China
2021-03-02 11:02 Illuminating the Heroes of Rare Diseases
2021-03-02 09:48 Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
2021-03-01 19:09 Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
2021-03-01 09:50 Journal of Allergy and Infectious Disease Review Confirms Nasal Hygiene Options Are Effective Tools as Part of Multilayered Defense Against COVID-19

Business Wire Weibo

Press Releases

Latest Releases